Skip to content
Search

Latest Stories

Hydrocortisone injection in limited supply - DHSC alerts pharmacists

Hydrocortisone injection shortage
Hydrocortisone injection in limited supply - DHSC

If stocks run out, prescribers are advised to consider switching patients to hydrocortisone sodium succinate 100mg powder for injection

Pharmacists are being notified of a limited supply of hydrocortisone sodium phosphate 100mg/1ml solution for injection ampoules, with stock expected to be exhausted by late March 2025.

The Department of Health and Social Care (DHSC) has issued a medicine supply notification, indicating that resupply is not anticipated until May 2026.


NHS provider Trust pharmacy procurement and clinical teams are advised to collaborate in reserving existing stock of the solution for injection, specifically for patients who require hydrocortisone sodium phosphate during an adrenal crisis.

The DHSC added that this stock has an expiry date of June 2025.

Hydrocortisone is used to replace steroids in individuals with adrenal insufficiency, such as those with Congenital Adrenal Hyperplasia (CAH) or Addison's disease, where the adrenal glands produce insufficient natural steroids.

People with adrenal insufficiency or anyone who is “steroid-dependent” require a hydrocortisone emergency injection kit to prevent an acute adrenal crisis, which can be life-threatening.

Symptoms of an adrenal crisis include extreme weakness, significant blood pressure drops, drowsiness, and confusion.

An emergency hydrocortisone injection, which can be administered by the patient or a friend or family member, can be life-saving until the patient receives further medical care.

Alternative option 

In cases where stock is exhausted, prescribers are advised to consider switching patients to hydrocortisone sodium succinate 100mg powder for injection, keeping in mind the difference in concentration after reconstitution.

“After reconstitution with 2ml diluent, the final concentration is approximately 50mg/ml,” the DHSC noted.

Prescribers should inform patients and/or carers who are used to administering the medication on how to reconstitute the hydrocortisone sodium succinate vial, making them aware of the concentration difference of the reconstituted solution to ensure the correct dose.

The DHSC has asked pharmacists to ensure that prescription for hydrocortisone sodium succinate powder for injection includes water for injection, unless the product with diluent is prescribed.

Furthermore, it is critical that wards, clinics, and emergency departments are informed of any changes in formulation and issue reconstitution advice, highlighting difference in concentration of the reconstituted solution.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less